entity

AGGREGATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections

30Hypotheses

4Analyses

0Outgoing

16Incoming

0Experiments

5Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (16)

Source	Relation	Type	Str
TDP-43	causes	protein	1.00
TAU	involved_in	protein	0.98
TDP-43	involved_in	protein	0.95
11050163	is mechanistically and temporally distinct from	paper	0.90
SNCA	involved_in	protein	0.90
21209826	is required (though not sufficient) for	paper	0.90
21209826	is required, though not sufficient, for	paper	0.90
alpha_synuclein	causes	protein	0.90
SNCA	causes	protein	0.90
NACore	activates	protein	0.90
C-terminal truncations	activates	protein	0.90
alpha-synuclein	causes	protein	0.70
C-terminal peptides	inhibits	drug	0.70
C-terminal truncations	accelerates	protein	0.70
apoE4	causes	protein	0.70
21209826	is required for	paper	0.60

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P	0.868	als	-
Exosomal SNCA Propagation from Lysosome-Compromised Neurons	0.777	neurodegeneration	-
NRF2-Mediated Proteostatic Convergence: Shared Oxidative Str	0.700	neurodegeneration	-
VPS35 Retromer Dysfunction Creates a GCase Trafficking Bottl	0.700	neurodegeneration	-
SNCA Aggregation Hijacks the Endosomal Sorting Complex Requi	0.690	neurodegeneration	-

TDP-43 Liquid-Liquid Phase Separation Dominance in Stress Gr	0.650	alzheimers	-
HSP90-Tau Disaggregation Complex Enhancement	0.634	neurodegeneration	Tau propagation mechanisms and therapeut
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
m6A-dependent control of alpha-synuclein transcript fate and	0.626	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
H7: Aberrant RNA Template Switching Converts Granules to Agg	0.625	neurodegeneration	How do pathological stress granules tran
SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycl	0.621	neurodegeneration	What are the specific PTM changes in syn
Cell-state stratification is required to resolve Causal Sequ	0.612	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Cell-state stratification is required to resolve m6A RNA Mod	0.612	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-	0.600	neurodegeneration	What are the neuron-specific effects of
Aβ-induced downregulation of circPDS5B derepresses TDP-43 mR	0.595	neurodegeneration	What mechanisms drive TDP-43 pathology s
HSP90-Tau Disaggregation Complex Enhancement	0.575	alzheimers	Tau propagation mechanisms and therapeut
TREM2-complement-amyloid axis as therapeutic target for prot	0.550	unknown	-
Glucosylceramide accumulation nucleates alpha-synuclein aggr	0.525	parkinsons	GBA-Synuclein Loop Therapeutics for PD
Microbial Metabolite-Mediated α-Synuclein Disaggregation	0.511	neurodegeneration	What are the mechanisms by which gut mic
TDP-43 Phase Separation Destabilization Drives Cytoplasmic A	0.500	neurodegeneration	Test
Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence	0.500	molecular-biology	What is the optimal therapeutic window t
Aggregation-prone sequences trigger HSP90-dependent conforma	0.497	protein-biochemistry	Do chaperones selectively recognize path
G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-	0.490	neurodegeneration	How do disease-associated mutations in G
Caspase-2/3-mediated D421 truncation generates disease-speci	0.455	neurodegeneration	Which specific post-translational modifi
Glycan-Disrupting Tau Disaggregation	0.455	neurodegeneration	Do tau-containing vesicles exhibit uniqu
GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and	0.429	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
P2X7/P2Y12 Purinergic Signaling Connects Aβ Aggregation to S	0.423	neurodegeneration	How do perivascular cells specifically r

Mentioning Analyses (4)

Scientific analyses that reference this entity

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

APOE4 targeting in neurodegeneration

neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.777

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 7 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

What are effective therapeutic strategies for targeting APOE4 in Alzheimer's dis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Can computationally designed binders against alpha-synuclein realistically trans

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal th

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

closed · Rounds: 4 · Score: 0.95 · 2026-04-06

Related Research

Hypotheses and analyses mentioning AGGREGATION in their description or question text

HSP90-Tau Disaggregation Complex Enhancement

Score: 0.634 · neurodegeneration · 2026-04-16

## Mechanistic Overview HSP90-Tau Disaggregation Complex Enhancement starts from the claim that modulating HSP90AA1 with

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetic

Score: 0.626 · neurodegeneration · 2026-04-28

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetics should produce a measurable proximal p

H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone

Score: 0.625 · neurodegeneration · 2026-04-22

## Mechanistic Overview H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone starts from the claim

SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycling at Synaptic Term

Score: 0.621 · neurodegeneration · 2026-04-16

## Mechanistic Overview SYNJ1 Aggregation and Solubility Loss Impairs PI(4,5)P2 Cycling at Synaptic Terminals starts fro

Cell-state stratification is required to resolve Causal Sequence of TDP-43 Nucle

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: TDP-43, ALS. Averaging across

Cell-state stratification is required to resolve m6A RNA Modification and Alpha-

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: m6A, RNA, N6-, alpha-synuclei

Perturbation-first validation should precede therapeutic claims for m6A RNA Modi

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Perturbation-first validation should precede therapeutic claims for Causal Seque

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autopha

Score: 0.600 · neurodegeneration · 2026-04-21

## Mechanistic Overview Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome

Aβ-induced downregulation of circPDS5B derepresses TDP-43 mRNA translation in li

Score: 0.595 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex regulatory network involving circPDS5

HSP90-Tau Disaggregation Complex Enhancement

Score: 0.575 · alzheimers · 2026-04-02

## **Molecular Mechanism and Rationale** The heat shock protein 90 (HSP90) chaperone system represents a critical cellu